A 26-30 kDa developmentally-regulated tau isoform localized within nuclei of mitotic human neuroblastoma cells.
Tau isoforms migrating at 46-68 and 97-115 kDa were prominent within heat-stable Triton-soluble material, and were present in lesser concentration with Triton-insoluble cytoskeletons, derived from undifferentiated SH-SY-5Y human neuroblastoma cells. Conversely, a 26-30 kDa tau isoform was enriched in the cytoskeleton and detected at relatively minor levels within cytosolic fractions. Pulse labeling with 35S-methionine indicated that this 26-30 kDa "small tau" did not represent a breakdown product of larger isoforms. Since the nucleus is retained within the Triton-insoluble cytoskeleton, additional cultures were fractionated onto sucrose to obtain purified nuclei. The vast majority of small tau was recovered within purified nuclei. Small tau was reactive with tau antibodies directed towards N-terminal, C-terminal and central epitopes, further confirming that this small isoform was not derived from proteolytic cleavage of larger tau isoforms. Small tau demonstrated alkaline phosphatase-sensitive reactivity with multiple phospho-dependent tau antibodies. Small tau was depleted within 3 days of retinoic acid-induced differentiation, suggesting that the putative function of this isoform may be obsolete following terminal differentiation of neurons.
Department of Biological Sciences, University of Massachusetts at Lowell 01854, USA.
T B
TB
Shea
C M
CM
Cressman
D015153:Blotting, Western; D001932:Brain Neoplasms / Q000378:metabolism* / Q000648:ultrastructure; D002454:Cell Differentiation / Q000187:drug effects; D002467:Cell Nucleus / Q000378:metabolism*; D006801:Humans; D008938:Mitosis; D008970:Molecular Weight; D009447:Neuroblastoma / Q000378:metabolism* / Q000648:ultrastructure; D011233:Precipitin Tests; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D016875:tau Proteins / Q000096:biosynthesis* / Q000737:chemistry
D016875:tau Proteins; D014212:Tretinoin